Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)

NCT05402332 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation

Interventions

DRUG: AVTX-801
DRUG: Placebo

Sponsor

Eva Morava-Kozicz

Collaborators

[object Object]